Skip to main content
SpringerLink
Log in

VI.D.2. Pharmacologic Vitreolysis with Plasmin: Clinical Studies

  • Chapter
  • First Online:
Vitreous

  • 3182 Accesses

Abstract

Various retinal disorders, e.g., vitreo-macular traction syndrome, macular hole, macular pucker, and diabetic macular edema, have been attributed changes at the vitreoretinal interface resulting from traction and membranes caused by anomalous posterior vitreous attachment [1, 2]. The purpose of vitreous surgery is to break the links between the vitreous and the retina at the fovea to relieve vitreous traction and restore normal foveal configuration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sebag J. Anomalous PVD – a unifying concept in vitreo-retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2004;242:690–8.

    Article  PubMed  CAS  Google Scholar 

  2. Sebag J. Vitreous anatomy, aging, and anomalous posterior vitreous detachment. In: Dartt DA, Besharse JC, Dana R, editors. Encyclopedia of the eye, vol. 4. Oxford: Elsevier; 2010. p. 307–15.

    Chapter  Google Scholar 

  3. Sebag J. Pharmacologic vitreolysis (guest editorial). Retina. 1998;18:1–3.

    Article  PubMed  CAS  Google Scholar 

  4. Sebag J. Pharmacologic vitreolysis- premise and promise of the first decade. Retina. 2009;29:871–4.

    Article  PubMed  CAS  Google Scholar 

  5. Verstraeten TC, Chapman C, Hartzer M, Winkler BS, Trese MT, Williams GA. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol. 1993;111:849–54.

    Article  PubMed  CAS  Google Scholar 

  6. Hikichi T, Yanagiya N, Kado M, Akiba J, Yoshida A. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina. 1999;19:55–8.

    Article  PubMed  CAS  Google Scholar 

  7. Gandorfer A, Putz E, Welge-Lüssen U, Grüterich M, Ulbig M, Kampik A. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol. 2001;85:6–10.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  8. Kim NJ, Yu HG, Yu YS, Chung H. Long-term effect of plasmin on the vitreolysis in rabbit eyes. Korean J Ophthalmol. 2004;18:35–40.

    Article  PubMed  Google Scholar 

  9. Wang ZL, Zhang X, Xu X, Sun XD, Wang F. PVD following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy. Retina. 2005;25:38–43.

    Article  PubMed  CAS  Google Scholar 

  10. Hermel M, Mahgoub M, Youssef T, Azrak MI, Raza H, Alldredge C, Trese M, Williams GA, Hartzer M. Safety profile of the intravitreal streptokinase-plasmin complex as an adjunct to vitrectomy in the rabbit. Graefes Arch Clin Exp Ophthalmol. 2006;244:996–1002.

    Article  PubMed  CAS  Google Scholar 

  11. Gandorfer A, Priglinger S, Schebitz K, Hoops J, Ulbig M, Ruckhofer J, Grabner G, Kampik A. Vitreoretinal morphology of plasmin-treated human eyes. Am J Ophthalmol. 2002;133:156–9.

    Article  PubMed  Google Scholar 

  12. Li X, Shi X, Fan J. Posterior vitreous detachment with plasmin in the isolated human eye. Graefes Arch Clin Exp Ophthalmol. 2002;240:56–62.

    Article  PubMed  CAS  Google Scholar 

  13. Margherio AR, Margherio RR, Hartzer M, Trese MT, Williams GA, Ferrone PJ. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology. 1998;105:1617–20.

    Article  PubMed  CAS  Google Scholar 

  14. Chow DR, Williams GA, Trese MT, Margherio RR, Ruby AJ, Ferrone PJ. Successful closure of traumatic macular holes. Retina. 1999;19:405–9.

    Article  PubMed  CAS  Google Scholar 

  15. Wu WC, Drenser KA, Trese MT, Williams GA, Capone A. Pediatric traumatic macular hole: results of autologous plasmin enzyme-assisted vitrectomy. Am J Ophthalmol. 2007;144:668–72.

    Article  PubMed  Google Scholar 

  16. Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmology. 2000;107:1607–11.

    Article  PubMed  CAS  Google Scholar 

  17. Williams JG, Trese MT, Williams GA, Hartzer MK. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology. 2001;108:1902–5.

    Article  PubMed  CAS  Google Scholar 

  18. Azzolini C, D’angelo A, Maestranzi G, Codenotti M, Valle PD, Prati M, Brancato R. Intrasurgical plasmin enzyme in diabetic macular edema. Am J Ophthalmol. 2004;138:560–6.

    Article  PubMed  CAS  Google Scholar 

  19. Diaz-Llopis M, Udaondo P, Arevalo F, Salom D, Garcia-Delpech S, Quijada A, Romero FJ. Intravitreal plasmin without associated vitrectomy as a treatment for refractory diabetic macular edema. J Ocular Pharmacol Therapeutics. 2009;25:379–84.

    Article  CAS  Google Scholar 

  20. Elbendary AM, Elwan MM, Azzam HA, Eldeeb DR. Predictability of vitreous detachment following intravitreal plasmin injection in diabetic macular edema associated with vitreomacular traction. Curr Eye Res. 2011;36:534–9.

    Article  PubMed  CAS  Google Scholar 

  21. Tsukahara Y, Honda S. Autologous plasmin-assisted vitrectomy for stage 5 retinopathy of prematurity: A preliminary trial. Am J Ophthalmol. 2007;144:139–41.

    Article  PubMed  Google Scholar 

  22. Wu WC, Drenser KA, Lai M, Capone A, Trese MT. Plasmin enzyme-assisted vitrectomy for primary and reoperated eyes with stage 5 retinopathy of prematurity. Retina. 2008;28:S75–80.

    Article  PubMed  Google Scholar 

  23. Sakuma T, Mizota A, Inoue J, Tanaka M. Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol. 2010;150:876–82.

    Article  PubMed  CAS  Google Scholar 

  24. Udaondo P, Diaz-Llopis M, Garcia-Delpech S, Salom D, Romero FJ. Intravitreal plasmin without vitrectomy for macular edema secondary to branch retinal vein occlusion. Arch Ophthalmol. 2011;129:283–7.

    Article  PubMed  Google Scholar 

  25. Asami T, Terasaki H, Kachi S, Nakamura M, Yamamura K, Nabeshima T, Miyake Y. Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema. Ophthalmology. 2004;111:231–7.

    Article  PubMed  Google Scholar 

  26. Uemura A, Nakamura M, Kachi S, Nishizawa Y, Asami T, Miyake Y, Terasaki H. Effect of plasmin on laminin and fibronectin during plasmin-assisted vitrectomy. Arch Ophthalmol. 2005;123:209–13.

    Article  PubMed  CAS  Google Scholar 

  27. Young KC, Shi GY, Wu DH, et al. Plasminogen activation by streptokinase via a unique mechanism. J Biol Chem. 1998;273:3110–6.

    Article  PubMed  CAS  Google Scholar 

  28. Rizzo S, Pellegrini G, Benocci F, Belting C, Baicchi U, Vispi M. Autologous plasmin for pharmacologic vitreolysis prepared 1 hour before surgery. Retina. 2006;26:792–6.

    Article  PubMed  Google Scholar 

  29. Udaondo P, Diaz-Llopis M, Garcia-Delpech S, Cervera E, Salom D. Autologous plasmin for intravitreal injection without associated vitrectomy: a simple preparation method with streptokinase. Arch Soc Esp Oftalmol. 2008;83:153–4.

    Article  PubMed  CAS  Google Scholar 

  30. Díaz-Llopis M, Udaondo P, Salom D, García-Delpech S, Romero FJ. Intravitreal autologous plasmin without associated-vitrectomy. Pharmacological vitreolysis, a perfeccionated method using urokinase. Arch Soc Esp Oftalmol. 2008;83:291–2.

    PubMed  Google Scholar 

  31. Hermel M, Dailey W, Hartzer MK. Efficacy of plasmin, microplasmin, and streptokinase-plasmin complex for the in vitro degradation of fibronectin and laminin- implications for vitreoretinal surgery. Curr Eye Res. 2010;35:419–24.

    Article  PubMed  CAS  Google Scholar 

  32. Hermel M, Dailey W, Trese M, Hartzer MK. A disposable system for rapid purification of autologous plasmin as an adjunct to vitrectomy - performance and safety profile. Graefes Arch Clin Exp Ophthalmol. 2011;249:37–46.

    Article  PubMed  CAS  Google Scholar 

  33. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol. 1991;109:654–9.

    Article  PubMed  CAS  Google Scholar 

  34. Sebag J. Age-related differences in the human vitreoretinal interface. Arch Ophthalmol. 1991;109:966–71.

    Article  PubMed  CAS  Google Scholar 

  35. Nasrallah FP, Jalkh AE, Van Coppenolle F, Kado M, Trempe CL, McMeel JW, Schepens CL. The role of the vitreous in diabetic macular edema. Ophthalmology. 1988;95:1335–9.

    Article  PubMed  CAS  Google Scholar 

  36. Gandorfer A. Role of vitreous in diabetic macular edema. Retina. 2012;32:S211–5.

    Article  PubMed  Google Scholar 

  37. Sebag J, Buckingham B, Charles MA, Reiser K. Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch Ophthalmol. 1992;110:1472–9.

    Article  PubMed  CAS  Google Scholar 

  38. Sebag J. Abnormalities of human vitreous structure in diabetes. Graefes Arch Clin Exp Ophthalmol. 1993;231:257–60.

    Article  PubMed  CAS  Google Scholar 

  39. Sebag J, Nie S, Reiser K, Charles MA, Yu NT. Raman spectroscopy of human vitreous in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 1994;35:2976–80.

    PubMed  CAS  Google Scholar 

  40. Hikichi T, Fujio N, Akiba J, Azuma Y, Takahashi M, Yoshida A. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology. 1997;104:473–8.

    Article  PubMed  CAS  Google Scholar 

  41. Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol. 1996;122:258–60.

    Article  PubMed  CAS  Google Scholar 

  42. Lopes de Faria JM, Jalkh AE, Trempe CL, McMeel JW. Diabetic macular edema: risk factors and concomitants. Acta Ophthalmol Scand. 1999;77:170–5.

    Article  PubMed  CAS  Google Scholar 

  43. Bababeygy SR, Sebag J. Chromodissection of the vitreo-retinal interface. Retin Physician. 2009;6(3):16–21.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Nagoya University School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan

    Hiroko Terasaki MD, PhD & Tetsu Asami MD, PhD

Authors
  1. Hiroko Terasaki MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tetsu Asami MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroko Terasaki MD, PhD .

Editor information

Editors and Affiliations

  1. VMR Institute for Vitreous Macula Retina, Huntington Beach, California, USA

    J. Sebag

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Terasaki, H., Asami, T. (2014). VI.D.2. Pharmacologic Vitreolysis with Plasmin: Clinical Studies. In: Sebag, J. (eds) Vitreous. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1086-1_51

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1086-1_51

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1085-4

  • Online ISBN: 978-1-4939-1086-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation